TABLE 1

Anti-Fim2 and anti-Fim3 IgG in samples from Sweden trial I and anti-Fim2/anti-Fim3 ratio 1 month after dose 3 in a 2-, 4-, and 6-month vaccination schedulea

Vaccine groupNo. of childrenGMb (EU/ml)95% confidence interval of GM
DTaP5 anti-Fim218295.880.6–113.8
DTaP5 anti-Fim318214.612.4–17.2
DTaP5 anti-Fim2/anti-Fim3 ratio1826.65.8–7.4
DTwP anti-Fim214628.023.2–33.9
DTwP anti-Fim314617.715.4–20.3
DTwP anti-Fim2/anti-Fim3 ratio1461.61.4–1.8
  • a Values below the MLD were set to 1 for anti-Fim2 and to 0.5 for anti-Fim3.

  • b GM, geometric mean.